-   ABOUT US   -

Formed in January 2017, the QIMING USA team is focused on US-based Healthcare companies with close strategic links to Qiming China. Situated in the major life sciences hubs of Cambridge (MA), Palo Alto (CA) and Seattle (WA), our highly complementary team has 90+ years cumulative investing and operating experience alongside broad scientific and clinical expertise in the US and China.


We invest in disruptive technologies, platforms, and/or products that address significant unmet needs, that are driven by passionate and committed teams with the depth and experience to succeed, and that are capable of delivering outstanding returns to our investors. Qiming invests in companies where we can have a direct impact on success, leveraging our experience, network and energy to enable innovation and deliver patient benefit. We are looking for exceptional investment opportunities across three sectors: biopharmaceuticals, medtech including diagnostics, and digital health.

-   TEAM   -

  • Gary Rieschel

    Founding
    Managing Partner

  • Mark McDade

    Managing Partner

  • Chris Shen

    Managing Partner

  • Jennifer Hu

    Partner

  • Anna French

    Associate

-   PORTFOLIO   -

QIMING USA has been operational since January 2017, our portfolio includes the following companies:

ZappRx
Headquarters: Boston, MA
Website: https://www.zapprx.com/

ZappRx is a pioneering digital health company that is modernizing and simplifying the way specialty drugs are managed. We provide a secure, collaborative online platform that allows patients, physicians, and pharmacists to work together to improve patients’ access to treatment and deliver medicine faster.

Platelet Biogenesis
Headquarters: Boston, MA
Website: http://plateletbiogenesis.com/

Platelet BioGenesis is a Harvard University spinout that is making human platelets from stem cells. We have developed and patented a microfluidic bioreactor, and shown that functional platelets can be generated from human pluripotent stem cell cultures. By removing the volunteer donor, we can make platelets that are cheaper, safer, and available on demand.

myHealthTeams
Headquarters: San Francisco, CA
Website: https://www.myhealthteams.com/

MyHealthTeams creates social networks for communities of people facing chronic conditions. We believe that when people facing the same chronic condition are able to connect with and learn from each other, ask questions, get referrals and share tips with other people who personally understand what it’s like to face that condition, health outcomes improve.

ARMO Biosciences
Headquarters: Redwood City, California
Website: http://armobio.com/

ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors. Our robust pipeline includes validated product candidates aimed at treating a variety of cancers in combination with standard of care and emerging immunotherapies.

Twinehealth
Headquarters: Cambridge, MA
Website: https://www.twinehealth.com

Twine Health is a cloud-based collaborative care platform for chronic disease management. It consists of a patient engagement portal, a peer support network, a care management solution, and an outcome analytics tool. Our business focus is aimed at the workplace health and health coaching environment.

Kezar Life Sciences
Headquarters: San Francisco, CA
Website: http://kezarlifesciences.com/

Kezar Life Sciences was founded in 2015 by Christopher Kirk, Ph.D., John Fowler, and Jack Taunton, Ph.D. to discover and develop innovative new therapies targeting protein homeostasis. Kezar’s first drug candidate, KZR-616, a selective inhibitor of the immunoproteasome, entered clinical trials in 2016.

-   CONTACT US   -

  • QIMING CAMBRIDGE, MA OFFICE
    1 Broadway, 9th Floor
    Cambridge, MA 02142
  • QIMING SEATTLE, WA OFFICE
    2101 4th Avenue,  Suite 2300
    Seattle, WA 98121
  • QIMING PALO ALTO, CA OFFICE
    2225 E. Bayshore Road
    Palo Alto, CA 94303

-   THE MOHAMED CHAOUI VENTURE FELLOWSHIP   -

A former colleague of a QIMING USA partner and a true friend of the firm, Mohamed Chaoui recently passed away following a battle with lung cancer. He has inspired us to create a rolling fellowship designed to provide a unique QIMING USA experience for talented MBA, MD, PhD, PharmD or other advanced degree students.

Our aim is to engage 3 to 4 courageous people every 12 months--and we are starting now.         find out more